Speakers

The following speakers from leading pharmaceutical companies and from authorities will be lecturing at the Pharma Congress 2012:

• Nigel Bates, Pfizer Ltd, Great Abington, Cambridge, UK
  Head of the Engineering Sciences Group within the Devices Centre of Emphasis, based in Cambridge UK.
  
• Edgar Bauer, Bausch + Ströbel Maschinenfabrik Ilshofen GmbH + Co. KG, Ilshofen
  Mr Bauer (Area Sales Manager) has been in charge of the French market in the Sales Department since 2000.
  
• Dirk Beer, Nycomed GmbH, Singen, Germany
  Mr Beer is responsible for assessment of suppliers for packaging materials including auditing and handling of complaints.
  
• Dr Andrea Behrenswerth, Gerresheimer Bünde GmbH, Bünde, Germany
  Head of Quality Assurance within Gerresheimer Bünde.
  
• Dr Klaus Buchweitz, Sandoz AG, Holzkirchen, Germany
  Since 2011 head of Third Party Management.
  
• Gerald Bürkle, Vetter Pharma-Fertigung GmbH & Co. KG, Ravensburg, Germany
  Director Pharmaceutical Production.
  
• Philippe Cappuyns, Janssen Pharmaceutica
  Part of Global Technical Services within Janssen Supply Chain responsible for assessment of innovative technologies and the introduction of QbD in development and production.
  
• Dr Olivier Chancel, Merial, Toulouse, France
  Currently Head of Pharmaceutical Support in Merial.
  
• Piet Christiaens, Toxikon Europe NV, Heverlee, Belgium
  Mr Christiaens holds the position of Scientific Director.
  
• Peter Cornelis, Toxikon Europe NV, Heverlee, Belgium
  Mr Cornelis is Department Supervisor of the Microbiology and In-vitro Toxicology Department.
  
• William Dierick, TERUMO EUROPE NV, Leuven, Belgium
  William Dierick is Business Development Manager – Global Pharmaceutical Solutions of TERUMO.
  
• Christian Doriath, Lilly France SAS, Fegersheim, France
  At Lilly he is currently working as a Global Network Expert for the whole isolator’s technology.
  
• Dr Peter Gassmann, Cilag AG, Schaffhausen, Switzerland
  He joined the QA/QC department and is currently Director of Quality Operations and Tech Support.
  
• Jens Gemmecker, OPTIMA GROUP pharma GmbH, Mornshausen, Germany
  Sales manager at OPTIMA GROUP pharma, facility Mornshausen.
  
• Angela Gessler, Skan AG, Allschwil, Switzerland
  At Skan AG she supervises a laboratory for H₂O₂ decontamination studies as well as H₂O₂ low concentration measurements.
• Leopold Gruber, SBM Schoeller Bleckmann Medizintechnik Ges.m.B., Ternitz, Austria
  Mr Gruber was active from 1974 till the end of 2010 in the area of the design and sales in leading functions.
  
• Dr Roland Guinet, Consultant Regulatory Compliance Sites and Processes.
  From 2002-2011 GMP Inspector at AFSSaPS (French Agency for the Safety of Health Products).
  
• Henry Huang, AstraZeneca
  Senior Formulation Scientist.
  
• Dr Renaud Janssen, Helvoet Pharma Belgium, Alken, Belgium
  He is currently Global Director of Scientific Affairs for Helvoet Pharma worldwide.
  
• Dr Timo Krebsbach, Labor L+S AG, Bad Bocklet, Germany
  Dr Krebsbach is head of the sterility testing department and responsible for sterility tests performed in a cleanroom as well as in isolators.
  
• Jens Kubischik, Pall GmbH, Dreieich, Germany
  Mr Kubischik is project manager for single-use-disposables in Europe.
  
• Sigrid Lieb, Vetter Pharma-Fertigung GmbH & Co, KG, Ravensburg
  Sigrid Lieb is project manager for internal and investment projects.
  
• Dr Santiago Llovera, Boehringer Ingelheim Espana S.A., Sant Cugat des Vallès, Spain
  Dr Llovera is Injectable Manufacturing Manager.
  
• Dr Jörg Lümkemann, F. Hoffmann-La Roche AG, Basel, Switzerland
  He is in the development of parenterals and in charge of the implementation of new technologies in this area.
  
• Jack Lysfjord, Jack Lysfjord Consulting LLC, Minnetonka, US
  Mr Lysfjord is Consultant in the field of Strategic Aseptic Processing.
  
• Dr Jean-Denis Mallet, SNC Lavalin, Ivry-sur-Seine, France
  Director Pharma Europe, formerly Head of the French Pharmaceutical Inspection Department (AFSSAPS).
  
• Gert Moelgaard, NNE Pharmaplan, Søborg, Denmark
  Gert Moelgaard is Vice President for Innovation & Business Development in NNE Pharmaplan.
  
• Alessandro Morandotti, Nuova OMPI, Piombino Dese, Padova, Italy
  Alessandro Morandotti is leading the development of new sterile products within the R&D organisation.
  
• Alicia Mozzachio, FDA, USA
  Director Regulatory, Office of Manufacturing and Product Quality (OMPQ).
  
• Dr Daniel Müller, Regierungspräsidium Tübingen, Germany
  Dr Müller is GMP-Inspector with focus on biotechnological active ingredients and sterile drug products.
  
• Dr Wenzel Novak, groninger & co. gmbH, Crailsheim, Germany
  Dr Novak is responsible for pharmaceutical research and development.
  
• Franck Pavan, Pierre FABRE Medicament Production, Idron, France
  Business Development Manager focused on Strategy and Development of contract manufacturing.
  
• Matthias Poslovski, OPTIMA GROUP pharma GmbH, Schwäbisch Hall, Germany
  Director Technical Sales, responsible for US and South American markets.
  
• Dr Ingo Presser, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
  Dr Presser is in charge of the clinical trail supply and process transfer unit with the Process Science Department.
  
• Dr Heino Prinz, Wilco AG, Wohlen, Switzerland
  Dr Prinz is in charge of research and development.
  
• Dr Bernd Renger, Bernd Renger Pharma Consulting GmbH, Radolfzel, Germany
  He is running his own consultancy business and was prior Director of QC at Vetter Pharma-Fertigung.
  
• Harald Römer, Notter GmbH
  Mr Römer is consultant and also working for Notter in the field of application technology.
  
• Dr Uwe Rothhaar, Schott AG, Mainz, Germany
  He primarily focuses on the chemical resistance and mechanical stability of pharmaceutical primary packing.
  
• Hartmut Schaz, NNE Pharmaplan GmbH, Bad Homburg, Germany
  He is Senior Expert for Small Volume Parenteral Products and Director of the Board of NNE Pharmaplan India.
  
• Dr Hans-Georg Schindler, Seidenader Vision GmbH, Markt Schwaben, Germany
  Since 2006 responsible for development and integration of innovative inspection methods.
  
• Dr Thomas Scholzen,F. Hoffmann-La Roche AG, Basel, Switzerland
  Quality Management of primary packaging materials at Roche Global Supplier Quality Management.
• Dr Harald Stahl, GEA Pharma Systems
  Harald Stahl presently is Senior Pharmaceutical Technologist. He has published more than 20 papers on various aspects of pharmaceutical production.
  
• Christoph von Stenglin, OPTIMA GROUP pharma GmbH, Radolfszell, Germany
  Managing Director.
  
• Dr Alexander Sterchi, F. Hoffmann-La Roche AG, Basel
  Since 2008 he is heading Logistics, Services & Infrastructure.
  
• Klaus Ullherr, Robert Bosch GmbH, Crailsheim, Germany
  Mr Ullherr is Product Manager for the business fields syringes and cartridges.
  
• Benoît Verjans, Aseptic Technologies S.A., Les Isnes, Belgium
  He is currently Commercial Director of Aseptic Technologies, responsible of developing the sales of the closed vial technology worldwide.
  
• Dr Christian Vogt, Novartis Pharma Stein AG, Stein/Basle, Switzerland
  Dr Vogt is responsible for sterility testing and microbiological QA and QC.
  
• Dr Jürgen Werani, Schuh & Co. Komplexitätsmanagement AG, St. Gallen, Switzerland
  Formerly Executive Director of Pfizer Deutschland, today member of the executive board of Schuh & Co.
  
• Jörg Zimmermann, Vetter Pharma-Fertigung GmbH & Co. KG, Ravensburg, Germany
  Mr Zimmermann is Director Process Development and Implementation.